The Effect of Interleukin-6 on the Proliferation of Prostate Cancer Cells in Vitro and the Modulation of This Procedure

被引：0
|
作者：
邢毅飞
肖亚军
张齐钧
鲁功成
机构：
来源：
Current Medical Science | 2001年 / 03期
关键词：
interleukin-6; prostate cancer; dexamethasone; crystal violet;
D O I：
暂无
中图分类号：
R737.25 [前列腺肿瘤];
学科分类号：
100214 ;
摘要：
The role of interleukin-6 (IL-6) in the growth of an androgen-independent prostate cancer cell line (PC-3m) was defined and the effect of dexamethasone, which was previously shown to modulate IL-6/IL-6 receptor (IL-6R) on this procedure was investigated. By using a pretty sensitive and specific enzyme immunoassay (ELISA), it was found that PC-3m produced certain IL-6, but there was no difference in IL-6 secretion between the group with or without dexamethasone treatment. It was also found that PC-3m cells could not be stimulated to grow by exogenous IL-6 (P>0.05), while it could be inhibited to grow by anti-IL-6 monoclonal antibody and dexamethasone with a dose-dependent fashion. Our observation indicated that IL-6 acted as an autocrine growth factor for PC-3m, and dexamethasone could inhibit cell proliferation by a mechanism independent of its effect on IL-6 mRNA expression.
引用
收藏
页码：225 / 227
页数：3
相关论文
共 50 条
  • [41] Interleukin-6: A multifunctional targetable cytokine in human prostate cancer
    Culig, Zoran
    Puhr, Martin
    [J]. MOLECULAR AND CELLULAR ENDOCRINOLOGY, 2012, 360 (1-2) : 52 - 58
  • [42] Role of interleukin-6 gene polymorphisms in the development of prostate cancer
    Chen, C. H.
    Gong, M.
    Yi, Q. T.
    Guo, J. H.
    [J]. GENETICS AND MOLECULAR RESEARCH, 2015, 14 (04) : 13370 - 13374
  • [43] Interleukin-6 is an autocrine growth factor in human prostate cancer
    Giri, D
    Ozen, M
    Ittmann, M
    [J]. AMERICAN JOURNAL OF PATHOLOGY, 2001, 159 (06): : 2159 - 2165
  • [44] Mechanism for bone invasion of oral cancer cells mediated by interleukin-6 in vitro and in vivo
    Okamoto, M
    Hiura, K
    Ohe, G
    Ohba, Y
    Terai, K
    Oshikawa, T
    Furuichi, S
    Nishikawa, H
    Moriyama, K
    Yoshida, H
    Sato, M
    [J]. CANCER, 2000, 89 (09) : 1966 - 1975
  • [45] Regulation of growth of prostate cancer cells selected in the presence of interleukin-6 by the anti-interleukin-6 antibody CNTO 328
    Steiner, Hannes
    Cavarretta, Ilaria T.
    Moser, Patrizia L.
    Berger, Andreas P.
    Bektic, Jasmin
    Dietrich, Hermann
    Zaki, Mohamed H.
    Nakada, Marian
    Hobisch, Alfred
    Nemeth, Jeffrey A.
    Culig, Zoran
    [J]. PROSTATE, 2006, 66 (16): : 1744 - 1752
  • [46] Blockade of interleukin-6 receptor suppresses the proliferation of cancer stem cells in H460 lung cancer cells
    Kim, N. H.
    Yi, H.
    Cho, S. M.
    Jo, K.
    Park, J. A.
    Cho, H. J.
    Kim, J. S.
    Shin, C. H.
    [J]. JOURNAL OF VETERINARY PHARMACOLOGY AND THERAPEUTICS, 2012, 35 : 170 - 170
  • [47] Modulation and termination of interleukin-6 signalling
    Heinrich, PC
    Bode, JG
    Graeve, L
    Haan, C
    Martens, A
    Müller-Newen, G
    Nimmesgern, A
    Schaper, F
    Schmitz, J
    Siewert, E
    [J]. EUROPEAN CYTOKINE NETWORK, 2000, 11 (03) : 512 - 513
  • [48] Regulation of interleukin-6 expression in human osteoblastic cells in vitro
    Hierl, T
    Börcsök, I
    Sommer, U
    Ziegler, R
    Kasperk, C
    [J]. EXPERIMENTAL AND CLINICAL ENDOCRINOLOGY & DIABETES, 1998, 106 (04) : 324 - 333
  • [49] Interleukin-6 increases the survival of retinal ganglion cells in vitro
    Torres, PMM
    de Araujo, EG
    [J]. JOURNAL OF NEUROIMMUNOLOGY, 2001, 117 (1-2) : 43 - 50
  • [50] Role of the brain in interleukin-6 modulation
    Terreni, L
    De Simoni, MG
    [J]. NEUROIMMUNOMODULATION, 1998, 5 (3-4) : 214 - 219
12345